# Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus

> **NCT01721460** · PHASE4 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 6 (actual)

## Conditions studied

- Parkinson's Disease
- Deep Brain Stimulation Surgery

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT01721460
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721460, "Effects of Dexmedetomidine on Activity in the Subthalamic Nucleus". Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/clinical/NCT01721460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*